Communiqués

04/09 Prenetics Global : Amendment to Annual Report by Foreign Issuer (Form 20-F/A) PU
27/08 Prenetics' IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results AQ
26/08 Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results AQ
20/08 Prenetics’ IM8 Announces Two-Time Golden Globe-Nominated Actress and Producer Lily Collins as IM8 Global Ambassador and Shareholder in Multi-Year Partnership AQ
18/08 Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond AQ
18/08 Prenetics Global : 2Q26 Letter to Shareholders PU
17/08 Prenetics, Parent of IM8, Appoints II Ranked, Caroline Levy, Veteran Wall Street Consumer Analyst as Independent Director AQ
10/08 Prenetics Global to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference Participation AQ
07/08 Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference Participation AQ
30/07 Prenetics Global : Amendment to Annual Report by Foreign Issuer (Form 20-F/A) PU
14/07 Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF) AQ
10/06 Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue AQ
04/06 Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion AQ
20/05 Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership AQ
14/05 Prenetics Global : 1Q26 Earnings Presentation PU
14/05 Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8 AQ
14/05 Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M AQ
08/05 Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call AQ
07/05 Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership AQ
14/04 Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One AQ
02/04 Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership AQ
24/03 Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation AQ
18/03 Prenetics to Participate in the 38th Annual ROTH Conference AQ
06/03 Prenetics Authorizes $40 Million Share Repurchase Program AQ
03/03 Prenetics Executives Execute Second Consecutive Round of Post-Earnings Open Market Share Purchases of $1.3 Million— Cumulative Personal Investment Across Both Rounds Reaches $2.7 Million AQ
Aucun résultat pour cette recherche